Watchman: Dr. Eads Explains, “There Is No New Pandemic. COVID-19 Was Never Proven to Exist. In Fact, It’s a Bioweapon. It’s Always Been a Bioweapon. The Variants Are Bioweapons. The Variants Are in the Kill Shots

HNewsWire: By Greg Hunter Dr. Betsy Eads warned about extreme disease and death coming because of the CV19 bioweapon/vax.  She was one of a handful of doctors who told the truth and said everything about CV19 from infection to injection was a lie.  She has been proven 100% correct. Now, the evil murderous Deep State globalist monsters have a fresh CV19 psyop.  They are pushing a new round of deadly and debilitating injections. The real story is the CV19 vaxed are the real problem, and we have a “pandemic of the vaccinated.”  There is new evidence that the CV19 vaxed are the “superspreaders” of sickness and disease. Dr. Eads explains, “There is no new pandemic.  Covid 19 was never proven to exist.  In fact, it’s a bioweapon.  It’s always been a bioweapon.  The variants are bioweapons.  The variants are in……...

Please join to continue reading. The truth is paywalled, but the lies are free. This content is for Monthly and Annual members only.
Login Join Now
Read More

Is China Harvesting DNA for Biological Warfare?

FF Gene Biotech is a next generation DNA sequencing company in China and was founded by Fulgent Genetics which is a primary distributor of COVID-19 tests nationwide. As of January 12, 2021, LA county announced it’s intent on relying on Fulgent Genetics to provide covid tests moving forward. Little does America know, FF Gene Biotech has set up shop in China to conduct cutting edge research on next generation DNA sequencing. The official relationship between the two companies is briefly explained on their site as follows: FF Gene Biotech formed in 2017 through a Joint Venture between Fulgent Genetics, Xilong Scientific, and Fuzhou Jinqiang Investment Partnership (FJIP). The company was founded to bring Fulgent Genetics’ next-generation sequencing (NGS) capabilities to the Chinese genetic testing market. On May 10th, 2021, Fulgent Genetics acquired a majority stake in FF Gene Biotech. The…

Loading

Read More